Authors
Latest:
How to Leverage Social Media to Build Your Personal Brand and Stand OutHaving a PharmD is an exceptional accomplishment, but it’s what you do with it that will empower you to dominate your career.
Latest:
New Congress Offers Expert Evaluation of Latest Neurology TrendsThe 1st annual International Congress on the Future of Neurology will be held on September 27-28, 2019 in New York City, featuring a rigourous agenda of presentations, question and answer sessions, and lightning rounds highlighting topics across the breadth of neurology.
Latest:
Patient Education: Depression: Beating the BluesThis article will help patients with depression to understand their treatment options and know what to expect from their medications.
Latest:
Helping Patients Manage Cardiovascular DiseaseAdherence to medications can aid in preventing and treating CVD.
Latest:
Improving Medication Reconciliation Accuracy in a Primary Care PracticeAccurate medication reconciliations are critical for ensuring safe patient outcomes, and a correct medication list can help prevent drug-drug interactions, contraindications, and duplicate therapies.
Latest:
Manage patient care your way … With support from an expert teamSponsored Content: If you’re ready to make a change, it’s time to explore owning a Medicine Shoppe International, Inc. (MSI) franchise of your own.
Latest:
Synchronization of Treatment With Erythropoiesis-Stimulating Agents and ChemotherapyIn outpatient oncology clinics, erythropoiesis-stimulating agents and chemotherapy were found to be typically administered during the same visits, as opposed to requiring separate visits.
Latest:
Impact of New Antihypertensives on Healthcare Utilization by Hypertensive PatientsThe authors advocate pharmacoeconomic evaluation of new antihypertensive drugs before acceptance by formulary decision makers.
Latest:
Maximizing Electronic Medical Records: The Electronic Medical Record Adoption Model and the Health-System PharmacistThere is growing confidence that health information technology investments will begin to meet expectations.
Latest:
The Legislative Framework for Dietary SupplementsWith the authority of the FDA limited by statute to removing supplements from the market only after reports of adverse effects, the role of pharmacists to intervene and assist patients with optimal product selection is vital.
Latest:
Combating Advancing Cancers With CAR T-Cell TherapyImmunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.
Latest:
Moving Away from Pharmacist Efficacy and Toward Pharmacist Effectiveness: Refocusing Research that Generates Knowledge about Pharmacist-Provided ServicesResearch has led to significant discoveries regarding new drugs, disease pathways, and devices; new strategies for improving care delivery; and meaningful insights into patient behavior and engagement in their care.
Latest:
Kind of a Big Deal: Data Utilization in Specialty PharmacyThe pharmaceutical industry cherishes the diverse sets of feedback generated among parties operating in specialty pharmacy.
Latest:
Cost Impact of Switching From Metoprolol to Nebivolol for HypertensionA large single-payer administrative claims database was used to assess the economic impact of switching from metoprolol to nebivolol for the treatment of hypertension.
Latest:
A Linezolid Prior Authorization Program: Clinical and Economic OutcomesThis study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.
Latest:
Podcasts Deliver Information and News to Pharmacists, Students, and TechniciansIn a continuing quest to be a one-stop shop to pharmacy professionals and students, Pharmacy Times® has upped its game on the podcast front in 2021 and will continue to introduce more podcasts in 2022.
Latest:
COPD Medication Adherence and Persistence Among Managed Medicare EnrolleesThe authors evaluated the significance of Medicare prescription plan choice on chronic obstructive pulmonary disease maintenance medication adherence and persistence using Optum Research Database information.
Latest:
Wrapping Up an Exciting Year for PharmacyFrom a mega-pharmacy benefit merger to pharmacy robberies to a blockbuster drug going off patent, 2011 was a landmark year for the field of pharmacy.
Latest:
Effectiveness of Ezetimibe Monotherapy in Patients With HypercholesterolemiaThe effectiveness of ezetimibe monotherapy for lowering low-density lipoprotein cholesterol was assessed in a managed care population.
Latest:
Studies Demonstrate the Power of PrEPSeveral large investigations have demonstrated the considerable efficacy of TDF/FTC taken daily or intermittently, reducing the risk of HIV acquisition by more than 95% in high-risk individuals.
Latest:
Cancer Therapeutic Clinical Trials Supporting FDA Approval and Compendia InclusionEvidentiary standards for new or supplementary cancer therapeutic indication approvals by the FDA are consistent with off-label indication inclusions on Medicare-referenced compendia.
Latest:
NASP: Specialty Medication Benefits Must be Thoroughly VettedSpecialty pharmacy is like the quarterback for care, seamlessly coordinating what happens with the patient, doctors, drugs, and pharmacy.
Latest:
Clinical Outcomes of Oral Anticancer Regimens in NSCLC Patients Managed in an Integrated Health-System Specialty Pharmacy ProgramPharmacist interactions provide significant benefits for patients with non-small cell lung cancer treated with oral oncolytics.
Latest:
USP : Are You Protecting Yourself?Pharmacists and interns who prepare HDs or work in areas where these drugs are located are potentially at risk for these adverse health effects. It is important for us to understand the risks and be proactive about protecting ourselves.
Latest:
New and Novel HIV MedicationsCombination antiretroviral therapy (ART) has greatly reduced HIV-associated morbidity and mortality and improved the quality of life for those living with HIV.
